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Abstract We investigated natural killer (NK) cell cytotoxicity in healthy preterm and 
full-term newborns in comparison to adults, to elucidate the possible role of delivery 
mode in influencing the NK activity and to evaluate the NK activity In severe neonatal 
pathological conditions such as bacterial sepsis and recurrent infections. NK cell cyto-
toxicity was investigated using a 4 h 5 l Cr release assay with K562 ceils as targets 
expressed as percentage kill in the following study groups: full-term normal spontaneous 
vaginal delivery (n = 55), full-term caesarean section (n = 51), preterm normal sponta-
neous vaginal delivery (n = 34), preterm caesarean section (n = 28), bacterial sepsis 
(n — 15). recurrent neonatal infections (n = 8) and healthy adults aged between 22-42 
years (n = 89). NK activity for the normal newborns was determined in paired cord and 
2-4 day-old neonate blood. The NK cell cytotoxicity in healthy newborns was signifi-
cantly lower than in adults (P < 0.01). Prematurity was associated with a significant 
decrease in NK cell activity compared to full-term neonates (P < 0.05). The mode of 
delivery did not influence the NK cytotoxicity. In sepsis and recurrent infections, a 
dramatic decrease in NK cell cytotoxicity was seen related to healthy newborns 
(P < 0.01). 
Conclusion Natural killer cell cytotoxicity is deficient in both neonatal sepsis and 
recurrent infections. 
Key words Chromium release assay Natural immunity Neonatal pathology 
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Abbreviations FT-CS full-term caesarean section FT-NSVD full-term normal 
spontaneous vaginal delivery /FN Interferon IL interleukin NK natural killer 
PT-CS preterm caesarean section PT-NSVD preterm normal spontaneous 
vaginal delivery 
Introduction 
Natural killer (NK) cells are a distinct subpopulation of 
lymphocytes [12, 16] which in contrast with cytotoxic T 
lymphocytes (T killer cells) do not rearrange the T 
lymphocyte antigen receptor genes, do not have an 
antigen specific receptor and do not require previous 
antigenic activation [23]. NK cells can kill a variety of 
tumour cells and virally infected cells [5, 15, 17, 20. 21, 
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24. 48], Apparently they have a role in haematopoiesis. 
suppressing the development of haematopoietic pro-
genitors [8. 14. 41. 43). NK cell activity also seems to be 
the first line mechanism in transplanted organ rejection 
and graft survival [25. 27, 33, 45. 47). 
The mechanism of lysis is not well understood. 
Osmotic lysis mediated by perforins [3, 29. 30], necrosis 
and apoptosis are the most important mechanisms of 
target cell killing [49]. 
NK cytotoxicity is subject to a complex regulation. 
Pro-inliammatory mediators such as interleukin-2 (IL-2), 
and interferon (IFN) y were shown to be NK activity 
augmenting cytokines, both in adults and neonates [4,19] 
Incubation of cord cells with IL-15 and IL-12 results in 
an increase in NK cell cytotoxicity. IL-15 increases the 
number of NK cells, suggesting that it might be clinically 
useful in treating immunodeficient patients [34, 35]. In 
contrast, IL-4, a known Th2-type cytokine, is a potent 
suppressor of NK cell mediated necrotic and apoptotic 
cytotoxicity [I I]. Other bioactive molecules such as 
hormones and several drugs might also modulate NK cell 
function. The NK activity depressing effect of theophy-
line, epinephrine, corticosteroids and members of the 
arachidonic acid cascade such as prostaglandin E2 has 
been well documented [6, 22, 26, 32, 36, 42], 
Fetal and neonatal NK cell activity is significantly 
decreased compared to adults [13, 28] which explains the 
increased neonatal susceptibility to infections. Until 
now, no neonatal normal values of NK activity were 
established. Data concerning the N K activity in health 
threatening conditions such as neonatal sepsis and 
recurrent infections are also missing. The endocrine-
metabolic and immune variations observed after differ-
ent degrees of delivery-related stress and the anaesthetic 
drugs given to the mother during caesarean section might 
influence cord blood N K activity. In the present work we 
investigated the role played by the N K cell cytotoxicity in 
recurrent infections and neonatal sepsis contrasted to 
healthy neonatal and adult NK activity as well as the 
possible influence exerted by the mode of delivery. 
Patients and methods 
The study was previously approved by the Human Investigation 
Review Board and blood samples were collected after informed 
consent had been obtained. According to the mode of delivery and 
gestational age four study groups were established: full-term nor-
mal spontaneous vaginal delivery (FT-NSVD, n = 55), full-term 
caesarian section (FT-CS, n = 51), preterm normal spontaneous 
vaginal delivery (PTT-NSVD, n = 34) and preterm caesarean section 
(PT-CS, n = 28). In each case venous blood was obtained a t the 
time of delivery f rom the cord vein and after 2 -4 days by veno-
puncture of a peripheral vein of the newborn. T w o additional 
categories were established for the study of N K cell cytotoxicity 
related to neonatal infection. The first group consisted of 15 new-
borns. who were diagnosed with sepsis by positive b lood cultures. 
The second pathological populat ion consisted of eight different 
newborns who presented a primitive, early onset infection at birth 
or within the first days of life and during hospitalisation developed 
a secondary infection such as bacterial sepsis, pneumonia and/or 
fungal infection occurring consequently within 28 days of life. The 
septic newborns from the first group were infected with group B 
streptococci (n •= 6). Listeria monocytogenes In = 3) or Escherichia 
coli In = 6). Newborns having recurrent infections In = 8). in 
addition to Escherichia coli. Listeria monocytogenes or group B 
streptococci positive blood cultures, later developed pneumonia 
and/or Candida albicans generalised infections. 
Both full-term and preterm healthy neonates irrespective of the 
mode of delivery were appropriate for gestational age. born to 
healthy mothers with negative medical and obstetrical history 
having a 5 min Apgar score >7. a t 38-42 and 31-37 weeks of 
gestation, respectively (mean gestational age ±. S D was 39.5 = I.I 
weeks for F T - N S V D . 39.6 ± 1.5 weeks for FT-CS. 34.4 = 1.8 
weeks for PT-NSVD and 34 ± 1.7 weeks for PT-CS). Septic 
newborns and those having had recurrent infections were appro-
priate for gestational age. born at 31-42 weeks of gestation with 5 
min Apgar scores of 6 -8 and with a maternal history of fever 
( temperature > 38 °C) and/or premature rupture of membranes 
greater than 24 h (mean gestational age ± S D for septic newborns 
and those having had recurrent infections were 35.7 = 3.3 and 
32.6 - 1.4 weeks, respectively). In these cases, mothers were 
treated with antibiotics. Neonatal N K activity was compared to 
healthy adults aged between 22-42 years In = 89). 
Natural killer cell cytotoxicity assay 
T h e N K cell cytotoxicity was measured using the s tandard 4 h 5 'O r 
release cytotoxicity assay as previously described [37]. Briefly, 
peripheral blood mononuclear cells were isolated f rom heparinised 
venous blood samples on Fycoll-Hypaque gradient (Pharmacia. 
Piscataway, N.I . ) Blood samples were processed within 12 h f rom 
the time obtained. After washing, the cell count was adjusted to 
2 x I06 viable cells/ml in R P M I 1640 containing 10 m M HEPES. 
10% fetal calf serum, 100 IU/ml penicillin and 100 pg/ml strepto-
mycin (all f rom Sigma, St. Louis, MO.) As targets we used 
3 lCr-labelled K562 human erythroleukaemic cells. Prior to the 
experiments, K562 cells were maintained in complete medium 
without H E P E S but with 5 m M extra L-glutamine and 60 pg/ml 
Tylocine. For labelling, 10s target cells in 100 pi of medium were 
incubated with 100 pCi o f 3 1 Cr (sodium chromate) in physiological 
saline solution. The labelled cells were washed three times in 
medium and resuspended at the appropr ia te concentration, usually 
3 x 104 cells/ml in order to give 3,000 cells/well. Prior to each 
experiment the viability of both target and effector cells was tested 
using Trypan blue exclusion. Effector and target cells were than 
co-cultured in 96 well V-bottomed microplates at various effector-
target cell ratios ranging f rom 100:1 to 3:1, achieved by making 
serial doubling dilutions of the effector cell suspension. The six 
effector-target ratios used were set up in triplicate. The plates were 
then centrifuged a t 150 x g for 1 min and placed in a 37 °C 
humidified 5 % C 0 2 incubator for 4 h. Thereaf ter the plates were 
centrifuged again for 10 min and 100 pi aliquots were removed for 
counting in a gamma counter. The cpm of the total incorporated 
label was determined by resuspending the target cells and 
harvesting 100 pi. The percentage cell mediated lysis ( % C M L ) was 
calculated as follows: 
% C M L = {(cpm(test) - cpm(medium)| 
/ [cpm(max) - cpm(medium)]} x 100% 
The Student s /-test was used to determine differences in NK cell 
cytotoxicity a t the effector-target cell ratio a t 50:1 and differences in 
slopes. 
Results 
NK cytotoxicity of healthy neonates proved to be sig-
nificantly lower than in adults as indicated by our 5 l Cr 
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Fig. 2 Comparison between average percentage kill ± 1 SD values 
for full-term (n = 106) and preterm (n = 62) healthy neonates at 50:1 
effector-target ratio showing a significant (P < 0.05) decrease in NK 
cell cytotoxicity of preterm neonates 
FT-NSVD and FT-CS were decreased, they were not 
statistically significant. 
The pathological cases (i.e. sepsis and recurrent in-
fections) demonstrated a marked failure of N K response 
in comparison to both adults and healthy neonates 
(P < 0.01). The average value of the percentage kill for 
septic neonates was never higher then 1.5%. Neonates 
having recurrent infections showed a slight but statisti-
cally not significant elevation of the NK cell cytotoxicity 
(3.5% kill at 50:1 effector-target ratio; Fig.l). At lower 
concentrations of the effector cells, the difference be-
tween percentage kill values of neonates diagnosed with 
recurrent infections and those having neonatal sepsis was 
only faintly evident. Similarly, when paired cord and 
neonate blood samples were analysed, no statistically 
significant difference was found. 
Discussion 
cytotoxicity assays (44.2 ± 5% kill for adults and 
26.6 ± 3.21% kill for the healthy neonatal population; 
P < 0.01) (Fig. 1). The possible role of the prematurity 
in influencing the cytotoxic activity of NK cells was also 
investigated. On the basis of the percentage kill values 
obtained, the preterm neonatal population compared to 
full-term healthy neonates showed a defective N K cell 
cytotoxicity, probably related to the immaturity of the 
immune system (P < 0.05) (Fig. 2). The influence of 
the delivery mode on neonatal NK cell response within 
the two populations (i.e. preterm and full-term healthy 
newborns) showed no significant differences at none of 
the effector-target ratios tested. Although the slopes of 
N K cytotoxicity versus effector to target ratios for 
The role of N K cells in normal immunity is not clearly 
established. These cells were attributed to antiviral and 
anti-neoplastic defence, however, neither viral infection 
associated nor tumour associated inflammatory infil-
trates show significant numbers of NK cells. The one 
setting in which large numbers of N K cells predominate 
in the lesions is the graft-versus-host disease in recipients 
of bone marrow transplants. During fetal development, 
N K cell activity can be first identified in the fetal liver at 
9 weeks of gestation. At 19 weeks, NK cell-like activity 
can be detected both in fetal liver and spleen and by 
the 28th week it appears in the peripheral blood as 
well [44, 46]. Previous studies have shown that at 
birth, healthy newborns have significantly lower N K 
activity than adults [7, 18]. Similarly the decreased NK 
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cytotoxicity of preterm versus full-term newborns has 
also been demonstrated [31. 40]. Our results are in per-
fect accordance with previously reported data. One 
possible explanation of the diminished NK activity seen 
in preterm newborns in comparison to that of full-term 
babies could rely on the insufficient maturation of the 
immune system. The concordance of our and previously 
reported data clearly demonstrates the reliability of our 
cytotoxicity assay. 
The decreased N K activity in bacterial sepsis and in 
recurrent infections was somewhat surprising because as 
we have already discussed, the physiological role of N K 
cells in natural immunity has been assigned mainly for 
antiviral, anti-tumoural and anti-graft defense. Recently 
considerable attention has been paid to the elucidation of 
the role that NK cells might play in antibacterial and 
antifungal defence. Previous studies revealed that human 
N K cells exhibit potent bactericidal activity against both 
gram-negative and gram-positive bacteria at least in 
vitro. Ultrastructural studies revealed close contact 
between NK membranes and bacteria without any 
evidence of phagocytosis [9]. Other studies proposed that 
NK cell-bacteria contact is not necessary for efficient 
killing [10]. In accordance with the later findings, other 
investigators have demonstrated that the antibacterial 
activity derived from human T and NK cells may be 
partly mediated by antibacterial peptides LL-37 and 
alpha defensins (HNP 1-3). These peptides were also 
shown to possess chemotactic activity for other immune 
effector cells such as polymorphonuclear leucocytes and 
CD4-positive T-lymphocytes [2]. In mice lacking func-
tional T cells, NK cell-derived IFNy was able to activate 
macrophages to kill infectious organisms such as Listeria 
monocytogenes [I]. Taken together all these results indi-
cate that NK cells are involved in antibacterial protection 
both through direct N K cell-bacteria contact, through 
antibacterial peptides and through a cross-talking 
between N K cells and other effector cells of the immune 
system via cytokines. In vitro studies of N K cell cytotoxic 
activity in adults with septic shock gave significantly 
lower results than in normal adults and this functional 
deficiency was paralleled by a severe decrease in N K cell 
number [38, 39]. This finding gave us the impetus to 
investigate the N K cell cytotoxicity in such an important 
clinical entity as neonatal sepsis and recurrent infection. 
Our results demonstrate that in these conditions the N K 
cell activity is dramatically decreased in comparison to 
normal preterm and full-term newborns. The lack of the 
diagnosis of an immunodeficiency syndrome further 
supports the significance of these results showing a 
decrease of NK cytotoxicity in severe bacterial infections. 
It is debatable if this insufficiency of N K cell function is a 
cause of the developing bacterial sepsis or it is rather an 
effect of this condition. This issue could be clarified by 
comparing NK cell cytotoxicity before and after sepsis 
and/or recurrent infection. However, the elucidation of 
this question was beyond the scope of the present study 
and awaits further investigation. To the best of our 
knowledge, this is the first publication showing a 
defective NK cell cytotoxicity in bacterial sepsis and re-
current infections of the neonate. 
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Abstract 
OBJECTIVES: To investigate the antioxidant defence potential of human neonates according to 
gestational age and mode of delivery. 
STUDY DESIGN: Four study groups were established: full-term normal spontaneous vaginal 
delivery (FT-NSVD, n=24), full-term caesarean section (FT-CS, n=19), preterm normal 
spontaneous vaginal delivery (PT-NSVD, n=15) preterm caesarean section (PT-CS, n=21). The 
activity of catalase (CAT), glutathion peroxidase (GPX), Cu/Zn superoxide dismutase (Cu/Zn-
SOD) were determined from cord blood. Statistical analysis was made by ANOVA. 
RESULTS: CAT activity was significantly higher in full-term than in preterm newborns. In both 
categories neonates born via caesarean section had significantly lower CAT activities. GPX activity 
was significantly higher in the FT-NSVD group than in any other group. Cu/Zn-SOD activity was 
significantly higher in full-term neonates than in preterms and no difference was found related to 
the mode of delivery. 
CONCLUSIONS: Prematurity and caesarean section may cause a deficiency of antioxidant defence 
in human newborn. 
Keywords: neonate, caesarean section, antioxidant enzymes, preterm newborn, full-term neonate 
Introduction 
Aerobic organisms possess antioxidant defense systems that deal with reactive oxygen species 
(ROS) as a result of aerobic respiration and substrate oxidation. ROS, including hydroxil radicals 
(•OH), superoxid anions (02*—) and hydrogen peroxide (H202), are generated in response to 
external and internal stimuli [1-3]. Low levels of ROS are necessary for several biological 
processes including intracellular differentiation and cell progression or arrest of growth, apoptosis, 
immunity and defense against microorganisms [4]. In contrast, high doses and/or inadequate 
removal of ROS result in oxidative stress, which may cause damages to biological macromolecules. 
The naturally occurring antioxidants in low-density lipoproteins (LDLs) and plasma protect cells 
from oxidation. The prevention of lipid peroxidation is an essential process because lipid 
peroxidation products can cause DNA damage and directly inhibit proteins such its Na+/K+-
ATPases and glutamate transporters [5]. 
The enzymatic antioxidant defenses include superoxide dismutase (SOD), glutathione peroxidase 
(GPX) and catalase (CAT). Superoxide dismutase (EC 1.15.1.1) is the antioxidant enzyme that 
catalyses the dismutation of the highly reactive superoxide anion to 02 and H202. In humans there 
are three forms of SOD: cytosolic Cu/Zn-SOD, mitochondrial Mn-SOD and extracellular SOD. 
Cu/Zn-SOD is believed to play a major role in the first line of antioxidant defense and high SOD 
activities were correlated with high immune competence [6]. CAT and GPX play an important role 
in the detoxification of H202. CAT (EC1.11.1.6) reacts very efficiently with I-I202 to form water 
and molecular oxygen and with hydrogen donors with peroxidase activity thus protecting cells 
against the H202 generated within them. GPX (EC 1.11.1.19) catalyses the reaction of 
hydroperoxides using GSH, protecting mammalian cells against oxidative damage. In fact 
glutathione metabolism is one of the most essential antioxidative defense mechanisms [7]. 
The onset of labor is associated with an increased production of proinflammatory mediators, which 
might induce an increase in the production of free radicals. In addition, oxygenation of both mother 
and child tissues oscillate frequently during labour, leading to an overproduction of free radicals as 
a consequence of tissue reoxigenation, which suggests that both maternal and fetal antioxidant 
systems might be overloaded during vaginal delivery [8]. This hypothesis is supported by several 
findings, including those which indicate that xanthine oxidase activity in placentae of labouring 
women was higher than in placentae obtained from pregnancies terminated by caesarean section. 
These data further indicate that labour might enhance free radical production [9]. However, the 
competence of enzymatic antioxidant systems through which the newborn might protect himself 
against an increased load of free radicals during labor depends on the gestational age, since 
antioxidant enzymes display lower activities during intrauterine life and in preterm than in full-term 
neonates [10, 11, 12]. Therefore, in the present study we proposed to elucidate the antioxidative 
enzyme activity in full-term and preterm neonates and the correlation between the way of delivery 
(per vias naturales vs. caesarean section) and the antioxidant defense systems of the newborn. 
Materials and methods 
Patients 
The study was previously approved by the Human Investigation Review Board, and blood samples 
were collected after informed consent had been obtained. According to the mode of delivery and 
gestational age four study groups were established: full-term normal spontaneous vaginal delivery 
(FT-NSVD, n=24), full-term caesarean section (FT-CS, n=19), preterm normal sponatneous vaginal 
delivery (PT-NSVD, n=15) and preterm caesarean section (PT-CS, n=21). In both the full-term and 
preterm category only elective caesarean section cases have been included. The indication for 
caesarean section was initiation of preterm labor and/or previous caesarean section associated or 
not with cephalopelvic disproportion. In each case venous blood was obtained at the time of 
delivery from the cord vein. 
Both full-term and preterm healthy neonates irrespective of the mode of delivery were appropriate 
for gestational age, born to healthy mothers with negative medical and obstetrical history having a 
five-minute Apgar score >7, at 38-42 and 31-37 weeks of gestation, respectively (mean gestational 
age ± SD was 39.22 ± 1.15 for full-term infants, 34.3 ± 1.6 weeks for preterm neonates, 39.1 ± 1.1 
weeks for FT-NSVD, 39.3 ± 1.3 weeks for FT-CS, 34.5 ± 1.8 weeks for PT-NSVD and 34 ± 1.8 
weeks for PT-CS). 
Determination of antioxidant enzyme activities 
Cu/Zn-SOD activity was determined via inhibition of the epinephrine-adrenochrorne autooxidation 
at 480 nm [13]. CAT activity was measured spectrophotometrically at 240 mil in aliquots of 
hemolysates. Enzyme activities were expressed in Bergmeyer units (BU). One BU is the amount of 
CAT that decomposes 1000 mg H202/min. GPX activity was determined in supernatant aliquots. 
As substrates reduced glutathione (GSH) and cumene hydroperoxide were used. GSH degradation 
was measured using Ellman's reagent [14, 15]. 
Other measurements 
Lipid peroxidation was determined with the thiobarbituric acid (TBA) method [15, 16] which 
determines the level of the total TBA-reactive substance. Plasma GSH was determined using 
Ellman's reagent. Protein content was determined using the Folin reagent [17]. 
Statistical analysis 
Statistical analysis of the data was made by ANOVA. For significant ANOVA values groups were 
compared by Tulcey's test for multiple comparisons with unequal cell size. A probability level of 
0.05 was accepted as indicating significant differences. 
Results 
CAT activity in healthy neonates proved to be significantly higher in the FT-NSVD category in 
comparison to PT-NSVD (average ± SE was 2.10 ± 0.16 nrBU/nrg protein for full-term healthy 
neonates and 1.86 ± 0.16 mBU/mg protein for the preterm healthy neonatal population). We found 
that the neonates born via cesarean section had a significantly lower CAT activity than the 
vaginally delivered babies in both the fiill-term and tire preterm category. (Figure I.A.). 
GPX activity showed to be significantly higher in the FT-NSVD category than in the other study 
groups (average ± SE for the FT-NSVD category was 1.25 ± 0.07 mU/mg protein whereas the 
values for the other study groups were 0.71 ± 0.14 mU/mg protein for FT-CS, 0.91 ± 0.08 raU/mg 
protein for PT-NSVD and 0.79 ± 0.19 mU/mg protein for PTCS). Tire comparison of the PT-NSVD 
group to the two cesarean section categories showed that tire average value of tire GPX activity was 
higher in this study population, however no statistical significance could be demonstrated (Figure 
l.B.) 
Cu/Zn-SOD activities were significantly elevated in the full-term neonates in comparison to the 
preterm population, irrespective to tire way of delivery (Figure I.C.). 
As for lipid peroxidation and GSH levels we could not find airy significant difference between the 
four study populations neither in the plasma nor in red blood cells (data not shown). 
Discussion 
Oxygen species are important participants in damage caused by virus infections, progression to 
cancer and neurodegenerative processes [18]. They can be toxic at the molecular level and they are 
important effectors in ageing and lifespan determination. Our study raised the question of possible 
correlation between tire antioxidant defense of the neonate and the way of delivery. This has been 
hypothesized by several recent findings, especially those which are indicating an increase in free 
radical production during vaginal delivery in contrast with ceasarean section, in which a diminished 
free radical load seems to be likely. Free radicals were reported to play an important role in the 
pathogenesis of several pathological conditions such as haemolytic disease of the newborn, 
bronchopulmonary dysplasia, and retinopathy of prematurity [19]. Indeed, neonates born by 
caesarean section have an increased incidence of these conditions. The involvement of oxidative 
damage in pathological pregnancies is another important issue with clinical relevance since in 
pregnancy induced hypertension an increased lipid peroxidation was reported, which may also 
impact on the vascular function and antioxidant status of the fetus [20]. However, the elucidation of 
this question was beyond the scope of our present work. Our results clearly show that the 
antioxidant defense mechanisms of the neonate are profoundly modulated by both the gestational 
age and the way of delivery, specifically the CAT activity is significantly higher in full-term than in 
preterm neonates and similarly, it is higher in neonates bom by spontaneous vaginal delivery, than 
in those which were bom by caesarean section. The other antioxidant enzyme activities were less 
affected by the way of delivery, but the gestational age proved to be a determinant factor of the 
activity levels. This later finding is in perfect accordance with previous data published by this 
laboratory and by other investigators, showing that the antioxidant status of preterm newborns is 
lower compared to full-term neonates [10], which emphasizes the reliability of our measurements. 
The significantly lower enzyme activities which were seen in premature newborns could partly be 
explained by the immature enzyme systems of these infants. However, recent data showing that the 
biosynthesis of glutathione was active in leukocytes from preterm infants seem to suggest that 
enzyme maturity is not always the limiting step in determining tire competence of cellular 
antioxidant systems [11]. The significance of our present findings is further emphasized by the fact 
that the study was conducted on purified study populations, excluding any pathological condition 
which might contaminate the results. 
Increased free radical production during labour suggests another interesting possibility which is that 
the oxidative burden of infants born via caesarean section might be lower, thus probably resulting 
in lower antioxidant enzyme expression, and lower activity levels, as well. This might explain our 
findings and could be addressed by investigating the expression of antioxidant enzymes at 
molecular level. 
Despite different antioxidant enzyme activities, the lipid peroxidation and GSH levels were not 
significantly different in die four study populations neither in plasma nor in red blood cells. This 
might indicate that in a population with negative internal medical and perinatal history the 
prematurity and/or caesarean section per se do not affect significantly lipid peroxidation. However, 
these data draw our attention to the fact that any concomitant disease condition which orchestrates 
tire mechanisms of oxidative stress may result in a more rapidly developing and more severe 
oxidative damage in premature neonates and in those bom via caesarean section. 
Based on our measurements we conclude that preterm babies and those born via caesarean section 
might be predisposed to pathological conditions in which reactive oxygen species may play a 
pathogenic role, due to deficient antioxidant defence. 
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Legend to figures 
Figure 1. Antioxidant enzyme activities in full-term normal spontaneous vaginal delivery (FT-
NSVD, n=24), full-term caesarean section (FT-CS, n=19), preterm normal spontaneous vaginal 
delivery (PT-NSVD, n=15) and preterm caesarean section (PT-CS, n=21) newborns. Enzyme 
activities were measured in cord blood hemolysates. Staistical analysis was made by ANOVA. For 
significant ANOVA values groups were compared by Tulcey's test for multiple comparisons with 
unequal cell size. A probability level of 0.05 was accepted as indicating significant differences. 
Groups marked in a similar way are not statistically different. A. Catalase (CAT) activity±SE in 
mBU/mg protein. B. Glutathione peroxidase (GPX) activity±SE in mU/mg protein. C. Copper-zinc 
superoxide dismutase (Cu/Zn-SOD) activity±SE in U/mg protein. 
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The possibility to use umbilical cord blood for transplantation in several enzyme 
deficiencies has received increasing attention because of the availability of cord blood, 
the reduced incidence of post-transplantation complications, such as graft-versus-host 
disease and die possible accomplishment of good corrective results following 
transplantation, even in case of greater HLA disparity. The use of hematopoietic stem 
cells from unrelated donors is even more recommendable for the treatment of inherited 
enzyme deficiencies, because it might reduce the risk of originating die transplanted cells 
from a carrier of the defect, which might have an inadequate corrective ability. Our study 
was designed to elucidate whetiier the gestational age and way of delivery influences die 
arylsulfatase-A activity in the umbilical cord blood. Enzyme activities proved to be 
similar in the four populations studied (full-term normal spontaneous vaginal delivery, 
frill-term caesarean section, preterm normal spontaneous vaginal delivery and preterm 
caesarean section). Therefore, umbilical cord blood samples seem to be suitable for 
transplantation in metachromatic leukodystrophy, regardless of gestational age and way 
of delivery. Moreover, our results are die first published data on normative values for 
arylsulfatase-A activity in human umbilical cord blood. 
Keywords: cord blood, arylsulfatase-A activity, gestational age, way of delivery 
Running Head: Arylsulfatase-A in human umbilical cord blood 
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Introduction 
Human lysosomal arylsulfatase-A (ASA) is a member of the highly conserved sulfatase 
gene family. It is synthetized as a 507 amino acid precursor and is processed in the 
endoplasmic reticulum to yield a mature 489 amino acid protein. Each sulfatase is 
characterized by high substrate specificity. From ten of the different human sulfatases 
which are known until today, six are located in tire lysosomes where they are responsible 
for tire degradation of glycosaminoglycanes and sulfolipids. Besides their physiological 
substrates arylsulfatases also degrade synthetic clxromogens and fluorogens.1 ASA's 
major natural substrate is cerebroside 3-sulfate which will accumulate if there is a 
deficiency in ASA, resulting in a lysosomal storage disorder, known as metachromatic 
leukodystrophy.2 
Recently, umbilical cord blood has received increasing attention as a source of unrelated 
hematopoietic stem cells for transplantation. Engraftment using umbilical cord blood has 
proven effectiveness in treating lysosomal diseases, as indicated by normalization of the 
defective enzymatic activity in such important clinical entities like globoid cell 
leukodystrophy, metachromatic leukodystrophy, mannosidosis, fucosidosis, 
aspartylglucosaminuria, Hurler, Maroteaux-Lamy, Sly syndromes and Gaucher disease 
Type III.3 The use of umbilical cord blood has several advantages above the well-known 
bone-marrow transplantation from unrelated donors, such as the ready availability of 
donor cells and the lower incidence of graft-versus host disease. The latter provides the 
ability to use umbilical cord blood even if there is a greater HLA disparity.4"6 
Pulklcinen et al.7 were the first who determined normative values for ASA and some 
steroid-sulfatases during intrauterine development. Previous results concerning the 
activity of a-glucosidase, mannosidase, fucosidase and ASA in chorionic villi did not 
show any correlation of enzyme activity with gestational age, except for a-glucosidase. 
Recent clinical data indicate that an incomplete reconstitution of the enzyme activity 
following the engraftment of bone-marrow cells from related donors who may carry the 
genetic defect (heterozygotes) results in a lessened improvement of the central nervous 
system status for diseases so treated, probably due to the inadequate corrective ability of 
the donor cells.9 Therefore, the correct choice of the donor is of particular importance. 
The use of umbilical cord blood for treatment of enzymatic defects seems to be a reliable 
alternative for bone-marrow transplantation. However, our present knowledge regarding 
the levels of activity of lysosomal enzymes in cord blood is related only to one 
pioneering study showing that a-L-iduronidase, galactocerebrosidase and ASA levels in 
cord blood do not differ from adult levels.10 Since no previous data exist regarding the 
levels of activity of ASA in umbilical cord blood related to gestational age and way of 
delivery, we cannot know if any cord blood sample, regardless the gestational age and 
way of delivery are equally effective in treating metachromatic leukodystrophy by 
transplantation. Therefore, the decision was made to investigate ASA activity in 
umbilical cord blood samples from preterm and full-term newborns, born by vaginal 
delivery and cesarean section. 
4 
Materials and methods 
Patients 
The study was previously approved by the Human Investigation Review Board, and 
blood samples were collected after informed consent had been obtained. According to the 
mode of delivery and gestational age four study groups were established: full-term 
normal spontaneous vaginal delivery (FT-NSVD, n=38), full-term caesarean section (FT-
CS, n=22), preterm normal spontaneous vaginal delivery (PT-NSVD, n=26) and preterm 
caesarean section (PT-CS, n=21). In both the full-term and preterm category only elective 
caesarean section cases have been included. In each case venous blood was obtained at 
the time of delivery from the cord vein. 
Both full-term and preterm healthy neonates irrespective of tire mode of delivery were 
appropriate for gestational age, bom to healthy mothers with negative medical and 
obstetrical history having a five-minute Apgar score >7, at 38-42 and 34-37 weeks of 
gestation, respectively (mean gestational age ± SD was 39.1 ± 1.1 weeks for FT-NSVD, 
39.3 ± 1.3 weeks for FT-CS, 35.5 ± 1.8 weeks for PT-NSVD and 35.2 ± 1.6 weeks for 
PT-CS). The entire patient population included in this study had negative anamnestic 
history in siblings, parents and grandparents for any inherited metabolic diseases. 
Determination of ASA activity in cord blood samples 
ASA activity was measured in leukocyte homogenates prepared from cord blood samples 
obtained at the time of delivery. Briefly, umbilical cord blood (10 ml) transported to the 
laboratory within 1 hour from the time obtained, was subjected to Ficoll-Hypaque 
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gradient centrifugation (Pharmacia, Piscataway, N.J.). After washing, the cell count was 
adjusted to 30><106 cells/ml in physiologic saline solution. The obtained cell suspension 
was then subjected to 5 freezing-thawing cycles in order to lyse the ceils. The cellular 
debries were removed from the lysed leukocyte suspension by centrifugation at BOOOxg 
for 10 min. The precleared leukocyte homogenate was further used for the determination 
of protein content by the method of Lowry et al.11 and for the direct measurement of ASA 
activity. 
ASA was assayed by the method of Singh et al.12 All the reagents used in the assay were 
purchased from Sigma (Budapest, Hungary). The assay was performed using 20 mM 
nitrocatechol sulfate as substrate in 0.2 ml M-sodium acetate buffer (pH 4.9), also 
containing 0.5 M Na4P207 and 1.7 M NaCl. To this, 200 pi of leukocyte homogenate was 
added and the mixture was incubated at 37 °C for 4 hours. The reaction was terminated 
by the addition of 100 pi 2.5 M NaOH and 100 pi 0.15 M EDTA. Liberated nitrocatechol 
was measured at 515 nm with nitrocatechol (20 pM) as standard, and ASA activity was 
expressed as nmoles nitrocatechol/h/mg protein. In the control samples leukocyte 
homogenate and substrate were incubated separately and mixed immediately prior to the 
addition of NaOH and EDTA. 
Statistical analysis 
Statistical analysis of the data was made by ANOVA. For significant ANOVA values 
groups were compared by Tukey's test for multiple comparisons with unequal cell size. A 
probability level of 0.05 was accepted as indicating significant differences. 
6 
Results 
The mean values of ASA activity in cord blood leukocytes are indicated in Figure I. No 
significant difference in ASA activity was detected in preterm versus full-term newborns 
(61.6 ± 41.4 for preterms and 67.6 ± 40.4 for full-terms; mean ± 1 SD) (Fig. 1A) In FT-
NSVD newborns the enzyme activity was 61.3 ± 35.2 (range 12.1-143). The mean ASA 
activity was slightly elevated in both the FT-CS and PT-CS category, whithout reaching 
statistical significance (87.5 ± 50.3, range 38-193 for FT-CS and 81.8 ± 39.6, range 43-
159 for PT-CS). In contrast, PT-NSVD infants had a lower ASA activity (31.4 ± 22.2 
range 9.6-68), which was not significantly different from the previous categories either, 
as shown by ANOVA (Fig. IB). The percentage of values below 30, which were 
considered as being indicative of a possible pseudo-deficiency was 18.4% for FT-NSVD, 
0% for FT-CS, 15.4% for PT-NSVD and 4.7% for PT-CS, respectively. The frequency of 
possible pseudo-deficiency on the basis of enzyme activity level below 30 for the full-
term population was 11.7% as well as for preterm newborns 10.6% (11.2% for the entire 
population). 
Discussion 
This is the first study determining the values of ASA in four different newborn 
categories. Prior to this study it has been shown that ASA activity of umbilical cord blood 
is equivalent to the activity of normal adults.10 Metachromatic leukodystrophy is an 
important pediatric disease which is inherited in an autosomal recessive maimer. Its 
incidence is particularly high in the North American and Eastern European population 
and represents an important burden for both the patient's parents and the health care 
7 
providers. Until the advent of the very promising new modality of treatment which is 
represented by the transplantation of bone-marrow derived cells thought to be able to 
overcome tire genetic defect, the traditional cure for this disease had very poor results. 
However, even this new treatment modality was shadowed by the important difficulties 
because of availability of suitable donors, which is significantly restricted due to HLA 
disparity. Whilst in other cases the most recommendable donor is a close relative of the 
patient, in the case of genetic disorders such as metachromatic leulcodistrophy the use of 
cells obtained from related donors is not recommendable because even if the donor is 
clinically healthy it cannot be ruled out that the related donor is a hétérozygote carrier of 
the genetic defect. This incovenience became evident after incomplete restauration of the 
enzyme activity resulting in a lessened improvement of the central nervous system status 
in patients so treated has been reported.9 Therefore, one possible alternative for bone-
marrow transplantation would be the engraftment of umbilical cord blood. In favor of this 
treatment modality pleedes the fact that umbilical cord blood is one of the most available 
sources of hematopoietic stem cells. Moreover, after umbilical cord blood 
transplantation, even in the case of a greater HLA disparity, the incidence of graft-versus-
host disease is lower. Thus the only limitation to the use of umbilical cord blood for the 
treatment of metachromatic leukodystrophy seems to be related to the possibility that the 
newborn from whom the cord blood had been obtained might be a carrier of the genetic 
defect as well. Another possible limitation to qualify as a donor is the high incidence of 
pseudodeficiency of the enzyme in the general population, which could be as high as 1,0-
15 %.13 The very recent data reported by de Gasperi and co-workers concerning the 
ASA activity in umbilical cord blood refer to a random neonate population, which 
S 
certainly increase the value of the reported data as reference values for the enzyme 
activity. However, our knowledge about the ASA activity in different newborn categories 
remains insufficient. The variation of enzyme activities with gestational age is not an 
uncommon phenomenon, raising the possibility that ASA activity could be lower in 
prematures than in full-term newborns. In the today's HMO oriented cost effective health 
care system the use of easy to obtain donor cells with maximal therapeutic potential and 
with minimal costs is highly recommended. Therefore tire study of the ASA activity in 
different newborn categories in order to verify the potential corrective ability of the cells 
to be engrafted and to establish the reference values of ASA activiy as a function of 
gestational age and way of delivery is of paramount importance. Our data clearly 
demonstrate that the activity of ASA is not different in any of the categories studied. 
Moreover, our data are comparable to those reported by de Gasperi et al.10 As a result, 
every normal newborn's umbilical cord blood could qualify equally effective as donor 
cell source for tire treatment of metachromatic leukodystrophy. However, before 
engrafting umbilical cord cells, the determination of the enzyme activity by a qualified 
laboratory in order to exclude any possible pseudodeficiencies would be recommendable. 
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Titles and legends to figures 
Arylsulfatase A (ASA) activity in human umbilical cord blood leukocytes. 
The bars represent the mean ± 1 SD values. A. Comparison between average enzyme 
activity for flill-term and preterm healthy neonates. B. Comparison between average 
enzyme activities in umbilical cord blood samples obtained from fiill-term normal 
spontaneous vaginal delivery (FT-NSVD), full-term caesarean section (FT-CS), preterm 
normal spontaneous vaginal delivery (PT-NSVD) and preterm caesarean section (PT-CS) 
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MALARIA DURING PREGNANCY AND ITS EFFECTS ON THE NEWBORN 
Harbans Lai* and V. K. Ahuja from Department of Pediatrics 
Medical College, Patiala, Punjab, India 
The effects of malaria during pregnancy as related to placental infection, transplacental 
transmission to the newborn and its impact on foetal growth were studied in 102 malarial 
mothers and their newborns and the results compared with normals. Malaria mostly due 
to P.vivax complicated 37.8% of the 448 consecutive deliveries. Placental infection, 
present in 68% of malarial pregnancies, was attended with higher incidence of placental 
and cord abnormalities. Transplacental transmission of infection was demonstrated in 4 
cases. Perinatal deaths increased by 23% in the babies born to the malarial mothers. 
The newborns of malarial mothers as compared to normals showed that their mean gesta-
tional age was shortened by 3.1 weeks along with 18.5% of increase in the incidence of 
preterm deliveries; the mean birth weight decreased by 395 gms. with 24.3% increase in 
the incidence of low birth weight deliveries. The mean values of various anthropometric 
measurements were significantly less in the newborns of malarial mothers as compared to 
normals. Maternal malaria is still a significant factor in the high perinatal morbidity 
and mortality in the tropics. 
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HUMAN CORD AND NEONATE BLOOD ARE DECREASED IN NATURAL KILLER CELL CYTOTOXICITY RELATIVE 
TO NORMAL ADULT BLOOD. Lee S. Berk, George D. Georgeson*, William C. Eby, Sandra L. 
Nehlsen-Cannarella, 0. Ward Swarner, Douglas D. Demming, Nancy Sancho, Daryl Vorce, 
and Leonard L. Bailey, Departments of Pathology' and Laboratory Medicine, Surgery and 
Pediatrics, Loma Linda University, Loma Linda, CA U.S.A. 92350. 
Because natural killer cell cytotoxicity (NKCC) is postulated to be involved in trans-
plant rejection and we are involved in neonate cardiac alio- and xenograft transplantion 
it is important to understand NKCC in neonates. Therefore, the purpose of this study 
was to determine normal values of NKCC in cord and neonate (2-4 days) blood for full 
term normal spontaneous vaginal delivery(FTNSVD) n=I5, full term cesarean section(FTCS) 
n=8, and preterm normal spontaneous vaginal delivery(PTNSVD) n=4, and to compare these 
with normal adult blood (NA), age 22 - 42 yrs, X=30. NKCC was measured by a standard 
4 hr. 5L-Cr release assay with the human tumor cell line K-562 as target cells. With 
target cells used at 2 x lCp/well, 6 different ratios of effector to target cells were 
studied with doubling dilutions from 3:1 to 100:1. The student's t-Test was used to 
determine differences in NKCC at the effector to target ratio of 50:1 and differences 
in slopes of NKCC vs. effector to target ratios. The results were as follows: Compar-
ing at a 50:1, FTNSVD, FTCS and PTNSVD cord blood with NA, the NKCC levels were all 
decreased (p<0.01); comparing at 50:1 FTNSVD and PTNSVD neonate blood with NA, NKCC 
levels were decreased (p<0.03), but FTCS was not significant. For the three neonate 
groups there was no statistically significant difference between cord and neonate blood 
The slopes of NKCC vs. effector to target ratios studied for PTNSVD cord and PTNSVD neo-
nate in comparison with NA were decreased (p<0.05 and p<0.01, respectively). Although 
the slopes of NKCC vs. effector to target ratios for FTNSVD and FTCS were decreased, 
they were not statistically significant. In conclusion, cord and neonate blood for 
the groups studied were found to be significantly less in NKCC than that of normal adult 
blood. This provides a better understanding of normal NKCC maturation in the neonate 
relative to transplantation and immunosuppression. 
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NATURAL KILLER CELL CYTOTOXICITY IN HUMAN CORD AND NEWBORN BLOOD. 
LS Berk,* GD Georgeson,* WC Eby,* J Peabody, and SL Nehlsen-
Cannarella.* Departments of Pathology, Pediatrics and Surgery, Loma 
Linda University, Loma Linda,CA 92350 
With the advent of heart, liver, and bone marrow transplantation in 
newborns and infants, a better understanding of normal newborn immun-
ity is necessary. Natural Killer Cell (NKC) Cytotoxicity has been 
implicated in transplant rejection and is a potential marker for fol-
lowing newborn and infant response to not only immunosuppressants and 
the rejection process, but also in immunopathology. However, no nor-
mal values for NKC activity in newborns exist. Therefore, we studied 
NKC in cord and newborn (2-4 days) blood and compared these with nor-
mal adult blood (NA) (22-42 yrs). Infants were grouped according to 
maturity and mode of delivery. NKC was measured by a standard 4 hr 
51-Cr release assay with K562 as the target cell line at 2x10 /well. 
The Student's t-test was used to determine differences in NKC. The 
results at the 50:1 ratio were significantly different, p<0.01, bet-
ween NA and both cord and newborn blood for all groups. The slopes 
for all these groups represented from a 3:1 to 100:1 ratio, with 
doubling dilutions were also significantly different from NA, p<0.01. 
No statistically significant difference was found between cord and 
newborn bloods within their respective group. However, preterm NKC was 
significantly lower than term NKC for cord natural spontaneous vaginal 
delivery and newborn cesarean section, p<0.01. Within a maturity 
group, there is no statistically significant difference in NKC between 
modes of delivery. In conclusion, NKC was found to be significantly 
decreased in cord and newborn blood, compared to adult normal values. 
These normal values may now be applied to studies of newborns and 
infants undergoing organ transplantation and in immunopathogenesis. . 
ELEVATED AMNIOTIC FLUID EPIDERMAL GROWTH FACTOR DURING LABOR. 
C Callegari,* JA Leake,* S Alvarez,* N Laborde, and DA Fisher, UCLA 
School of Medicine, Department of Pediatrics, Harbor-UCLA Medical 
Center, Torrance, CA. 
It has been postulated that prostaglandin (PG) production by the 
amnion may trigger parturition, and epidermal growth factor (EGF) has 
been reported to stimulate PGE2 production by amnion cells in culture. 
To date no data are available describing human EGF (hEGF) levels dur-
ing labor. We measured hEGF, creatinine and osmolarity in amniotic 
fluid (AF) before birth and/or the first (urine) void from newborns 
delivered by elective cesarean section (ECS) (AF 16, urine 7-total 
n=16) or normal vaginal delivery (NVD) (AF 12, urine 10-total n=20). 
AF was collected from the ECS patients by syringe aspiration when rup-
turing the membranes and from a pressure catheter during labor (118± 
66 min; X±SD before delivery) in the NVD subjects. hEGF was measured 
by RIA, using a recombinant DNA antigen (Chiron Corp.) with a sensiti-
vity of 15 pg/ml. The groups studied.were similar by gestational age; 
fetal sex, body weight, body length and apgar scores; AF and urine 
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NATURAL KILLER CELL CYTOTOXICITY IN HUMAN CORD AND ' 
NEWBORN BLOOD. Lee S. Berk, George D. Georgeson, 
•j or\/T William C. Eby, Joyce L. Peabody and Sandra L. 
1 Nehlsen-Cannarella. Departments of Pathology, 
Pediatrics and Surgery, Loma Linda University, Loma 
Linda CA 92350 (Spon. by Stephen Ashwal). 
With the advance in cardiac transplantation in newborns and 
infants, a better understanding of their normal immunity is 
necessary. Natural killer cell cytotoxicity (NKC) is implicated 
in transplant rejection and is a potential marker for following 
newborn and infant response to not only immunosuppressants and 
the rejection process, but also in immunopathogenesis. However, 
no normal values for NKC activity in newborn exist. Therefore, 
we studied NKC in cord and newborn (2—4 days) blood and compared 
these with normal adult blood (NA) (22-42 yrs). Infants were 
grouped according to maturity and mode of delivery. NKC was 
measured by a standard 4- hr 51-Cr release assay with K562 as the 
target cell. The Student's t-test was used to determine differ-
ences in NKC. Results at the 50:1 ratio were significantly 
different, p<0.01, between NA and both cord and newborn blood 
for all groups. Slopes for all these groups represented from a 
3:1 to 100:1 ratio were also significantly different from NA, p< 
0.01. Preterm NKC was significantly lower than term NKC for 
cord normal spontaneous vaginal delivery and newborn cesarean 
section, p<0.01. Within a maturity group, there is no 
statistically significant difference in NKC between modes of 
delivery. In conclusion, NKC was found to be significantly 
decreased in cord and newborn blood, compared to adult. These 
normal values may now be applied to studies in newborns and in-
fants undergoing organ transplantation and in immunopathology. 
SERIAL STUDIES OF CELL MEDIATED IMMUNITY IN INFANTS 
OF BIRTHWEIGHT LESS THAN 1300 GRAMS. James Bussel , 
1 / 2 Q H Michael Giuliano, Walter Greenfield, and Susanna 
l J ? ' Cunningham-Rundles (Spon by Margaret W. Hilgartner). 
Cornell Medical Center-New York Hospital, Department 
of Pediatrics. New York, NY. 
Limited studies exist of cell-mediated immunity (CMI) in very 
premature infants (VPI). We report here serial biweekly immune 
studies in 58 VPI of birthweight 700 to 1300 grams including pro-
liferative responses to PHA (standard methods using 50,000 cells 
per well in triplicate) and determinations of lymphocyte subpopu-
lations using % staining with 0KT3, 0KT4, and 0KT8 (flow cyto-
metry). The mean PHA response in VPI was 16,000 cpm ± 5.7k cpm 
(n=103), significantly decreased compared to term infants and 
adult normals 23.0k±4.5k; 41% of VPI were <14.0k cpm. The mean 
0KT3 was 64.6%±15 (n=89), significantly decreased compared to 
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Scand. J. Immunol. 26, 303-335. 1987 
Eighteenth Annual General Meeting of the 
Scandinavian Society for Immunology 
Uppsala, Sweden, 2-4 June 1987 
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DETECTION OF ANTIBOOYPRQOUCT'.ON AT SIKGU CELL LEVEL 
IN MYASTENIA GRAVIS:Richard A h l b e r q . M e t a A n d e r s s o n 
and Ann-Kar i L e f v e r t . D e p t . o f I n t e r n a l M e d i c i n e Ka ro -
l i n s k a I n s t i t u t e : 80* 60500 10401 S t o c k h o l m Sweden . 
In p a t i e n t s w i t h M y a s t e n i a Grav i s (MG) t h e r e i s a 
poor c o r r e l a t i o n b e t w e e n t h e l e v e l s of t h e s p e c i f i c a u t o -
a n t i b o d i e s i n se rum and t h e c l i n i c a l s y m p t o m s . T h i s i s 
p r o b a b l y due t o t h e l a r g e h e t e r o g e n e i t y of t h e A b - p o o u l a -
t i o n i n an i n d i v i d u a l w i t h MG.and t o t h e f a c t t h a t t h e 
A b ' s nay be r a p i d l y e l i m i n a t e d f r o m serum by b i n d i n g t o 
a n t i g e n ( A g ) o r t o c o m p l e m e n t a r y A b ' s . 
T h i s i m o l i c a t e s t h e need f o r e method t h a t d e t e c t s 
t h e A b - f o r m a t i o n a t t h e s i n g l e c e l l l e v e l . S u c h a method 
h a s r e c e n t l y b e e n d e s c r i b e d . T h e m e t h o d . t h e ELlSPOT-assay 
(Enzyme L inked Immuno S p o t ) , i s a m o d i f i c a t i o n of t h e EL ISA 
and i s b a s e d on t h e f o l l o w i n g p r i n c i p l e ; A g ' s a r e bound 
t o a memorane.A e e l l s u s p e n s i o n o f A b - f o r r a i n g c e l l s i s i n -
c u b a t e d on t h e memorane and t h e s e c r e t e d A b ' s b i n d s t o 
t h e A g . A - s e c o n d A b . c o n j u g a t e d t o an e n z y m e , i s added t o 
t h i s A g - A b - c o m p l e x . A d d i n q t h e s u b s t r a t e p r o d u c e s v i s u a b l e 
s p o t s c o r r e s p o n d i n g t o A b - f o r m i n g e e l I s . I n t h i s way t h e 
p r e v a l e n c e of c e l l s p r o d u c i n g s p e c i f i c A b ' s can be e s t i -
m a t e d . 
We a r e now a b o u t t o a d a p t t h i s method to s t u d y t h e 
s p e c i f i c A b - p r o d u k t i o n f r o m l y m f o c y t e s o r i g i n a t i n g f rom 
p e r i p h e r a l b l o o d . b o n e m a r r o w and t h y m u s . 
P R O L I F E R A T I V E C A P A C I T Y FROM LEUKEMIC C E L L S . 
A g u i L a r - S a n c e l i s e s . M . . C a r e l a . C . A . f J o n d a l , M. 
t M e l l s c e d t , H. f r o m : D e p a r t m e n t o f I m m u n o l o g y , 
K a r o L i n s k a I n s t i t u t e 1 D e p a r t m e n t o f O n c o l o g y , 
K a r o l i n s k a H o s p i t a l . 
I n o r d e r t o s t u d y g r o w t h c h a r a c t e r i s t i c s 
o f l e u k e m i c c e l l s f r o m c h r o n i c l y m p h o c y t i c l e u k e m i a 
( B - C L L l s u c h c e i l s h a v e b e e n s t i m u l a t e d w i t h d e -
f i n e d f a c t o r s o r c h e m i c a l s . T h e c e l l u l a r r e s p c r . - . 
s i y ç n e s s t o I L - 1 , I L - 2 BCGF (MP6 s u p e r n a t a n t ) , . 
Ca i o n o p h o r e a n d p h o r b o l e s t e r TPA h a s b e e n 
t e s t e d e i t h e r w i t h f a c t o r s a L o n e o r w i t h d i f f e r -
e n t c o m b i n a t i o n s t h e r e o f . 
I s o l a t e d B - C L L c e l L s w e r e f o u n d t o p r o -
l i f e r a t e i n r e s p o n s e t o I L - 1 , BCCF a n d , i n s o m e 
c a s e s , r e c o m b i n a n t I L - 2 . T h i s p r o l i f e r a t i o n w a s 
p o t e n t i a t e d b y T P A . I n c o n t r a s t , n o r m a l B l y m p h o -
c y t e s d e m o n s t r a t e d a d i f f e r e n t p a t t e r n o f r e s p o n -
s i v e n e s s . T h e e n h a n c e d p r o l i f e r a t i v e c a p a c i t y o f 
B - C L L c e l l s i n v i t r o m a y r e f l e c t a n a l t e r e d g r o w t h 
c o n t r o l i n v i v o a t s e l e c t e d r e s t r i c t i o n s p o i n t s 
i n t h e c e l l c y c l e . 
FACS ANALYSIS OF LYMFOCYTES FROM MINK INFECTED WITH ALEUTIAN 
DISEASE VIRUS. Bent Aasced . The Department of Veterinary 
Virology and Immunology, The Royal Veterinary and 
Agricultural University, Copenhagen. Denmark. 
Aleutian disease (AD) is a slowly progressing disease in 
mink. It is caused by persistent infection with Aleutian 
Disease Virus (ADV), a nondefective parvovirus. The disease 
is characterised by piasmacytosis, hypergammaglobulinemia 
and immune complex mediated glomerulonephritis and 
a r t e r i t i s . 
The cellular response during the infection has barely 
been studied. We have developed staining methods of 
ficoll-paque separated mink lymphocytes for FAC3 analysis, 
including surface-immunoglobulin staining, PflA (peanut 
agglutinin! staining and staining with a monoclonal 
anti-human CDd antibody which happened to stain quite 
strongly same mink lymphocytes. 
The FACS analysis of lymphocytes of normal mink as well 
as mink infected with Aleutian Disease virus will be 
presented. 
I L - 1 IN VITRO PRODUCTION BY LEUKEMIC C E L L S . 
A g u i l a r - S a n t e l i s e s , M . . G a r c i a , C . A . , J o n d a l , M . 
4 Mel 1 s t e d t , H . , f r o m : D e p a r t m e n t o f I m m u n o l o g y , 
K a r o l i n s k a I n s t i t u t e 4 O e p a r t m e n t o f O n c o l o g y , 
K a r o l i n s k a H o s p i t a l . 
We h a v e r e c e n t l y d e s c r i b e d I L - 1 l i k e 
s p o n t a n e o u s p r o d u c t i o n i n l e u k e m i c c e l l s . T h i s 
f a c t o r w a s i n v i t r o . c o - r a i t o g e n i c w i t h C o n A a n d 
w i t h n o n a i t o g e n i c c o m b i n a t i o n s o f p h o r b o l e s t e r 
a n d c a l c i u m i o n o p h o r e f o r m o u s e t h y m o c y t e s . Ue h a v e 
now a n a l y z e d s u p e r n a t a n t s f r o m PBL e i t h e r f r o m 
p a t i e n t s w i t h C h r o n i c L y m p h o c y t i c L e u k e m i a ( B - C L L ) 
o r a b e n i g n v a r i a n t w h i c h we h a v e c a l l e d Monoclona l 
L y m p h o c y t o s i s o f U n d e t e r m i n e d S i g n i f i c a n c e ( H L U S ) . 
Ue h a v e f o u n d p r o d u c t i o n o f I L - 1 l i k e a c t i v i t y i n 
t h e s u p e r n a t a n t s f r o m c u l t u r e d c e l l s a s d e t e r m i n e d 
by t h e t h y m o c y t e a s s a y a n d c o n f i r m e d t h e p r e s e n c e 
o f I L - 1 b y r a d i o i m m u n o a s s a y . T h e r e i s a l s o c o r r e l a t i o n 
w i t h t h e t h y m o c y t e a s s a y . T h e c o n c e n t r a t i o n i n t h e 
m a j o r i t y o f t h e s a m p l e s v a r y b e t w e e n 0 . Z S a n d 2 0 
n g / m l . MLUS p a t i e n t s ' c e l l s p r o d u c e s p o n t a n e o u s l y 
h i g h e r a m o u n t o f I L - l t h a n 8 - C L L p a t i e n t s ' c e l l s . 
The p r o d u c t i o n o f I L - l i s i n c r e a s e d w h e n e i t h e r 
MLUS o r 8 - C L L c e l l s a r e s t i m u l a t e d w i t h S t a p h y l o -
c o c c u s a u r e u s s t r a i n C o w a n 1 ( S A C ) by 2 4 h o u r s . 
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NATURAL KILLER CELL CYTOTOXICITY IN HUMAN CORD AND NEW-
BORN BLOOD. Lee S. Berk, George D. Georgeaon, Joyce L. 
Peabody Sandra L. Nehlsen-Cannarella, and William C. Eby, 
Dept. of Pathology Loma Linda Univ. and Medical Center, Rm 
1575, Loma Linda, CA 92350 USA 
With the advance in organ transplantation in newborns and 
infants, a better understanding of their lmmunogenesis is 
necessary. Natural killer cell cytotoxicity (NKC) is 
Implicated in transplant rejection and is a potential 
marker for following response to immunosuppressants and 
the rejection process. However, no normal values for NKC 
activity in newborn exist. Therefore, we studied NKC in 
cord and newborn (2-4 days) blood and compared these with 
normal adult blood (NA) (22-42 yrs). Infants were grouped 
according to maturity and mode of delivery. NKC was mea-
sured by a standard 4 hr 5I-Cr release assay with K562 as 
the target cell. The Student's t-test was used to deter-
mine differences in NKC. Results at the 50:1 ratio were 
significantly different, p<0.01, between NA and both cord 
and newborn blood for all groups. Slopes for all these 
groups represented from a 3:1 to 100:1 ratio were also 
significantly different from NA, p<0.01. Preterm NKC was 
significantly lower than term NKC for cord normal spont-
aneous vaginal delivery and newborn cesarean section p< 
0.01. Within a maturity group, there is no statistically 
significant difference in NKC between modes of delivery. 
In conclusion, NKC was found to be significantly decreased 
in cord and newborn blood, compared-to adult. These nor-
mal data may now be applied to clinical care of newborns 
and infants undergoing organ transplantation and pathology 
1 
SELECTIVE ACCEPTANCE OF MHC CLASS I DEFICIENT TUMOR GRAFTS 
IN THE BRAIN. H. G. Llunggren. T. Yamasaki, V. P. Collins, 
G. Klein and K. KSrre. Dept. of Tumor Biology, Karolinska 
Institutet, Stockholm, Sweden 
From the murine retrovirus induced leukemia RBL-5, readily 
expressing high a m o u n t s of c e l l s u r f a c e m a j o r 
histocompatibility complex (MHC) class I antigens, we have 
selected MHC class I deficient (H-2~) mutants. In contrast 
to other parts of the body, we show that the brain 
selectively will accept MHC class I negative tumor cell 
grafts. H-2" tumor cells inoculated intracranially (i.e.) 
rapidly grew out as solid tumors whereas the same H-2" 
cells were rapidly and efficently eliminated by a host, T-
cell independent, cell mediated immune defence mechanism 
after intravenious (i.v.), subcutaneous (s.c.) or 
intraperitoneal (i.p.) inoculation. This was in contrast to 
the H - 2 + c e l l s which were readily accepted both 
intracranially and extracranially. This indicates that the 
extracranial ly efficiently working immune response, 
selectively directed against MHC class I negative cells, is 
either suppressed or totally absent in the brain. These 
results will be discussed in relation to the different 
i m m u n o l o g i c a l s u r v e i l l e n c e m e c h a n i s m s working 
•intracranially and extracranially, with special regard to 
• unusally low expression of MHC class I molecules in the 
brain, the nature of the particular immuneresponses in the 
brain and to brain tumors. 
